159 related articles for article (PubMed ID: 32643269)
1. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.
Gohda T; Kamei N; Kubota M; Tanaka K; Yamashita Y; Sakuma H; Kishida C; Adachi E; Koshida T; Murakoshi M; Hagiwara S; Funabiki K; Ueda S; Suzuki Y
J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269
[TBL] [Abstract][Full Text] [Related]
2. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.
Kamei N; Yamashita M; Nishizaki Y; Yanagisawa N; Nojiri S; Tanaka K; Yamashita Y; Shibata T; Murakoshi M; Suzuki Y; Gohda T
Sci Rep; 2018 Oct; 8(1):15302. PubMed ID: 30333553
[TBL] [Abstract][Full Text] [Related]
3. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.
Oh YJ; An JN; Kim CT; Yang SH; Lee H; Kim DK; Joo KW; Paik JH; Kang SW; Park JT; Lim CS; Kim YS; Lee JP
PLoS One; 2015; 10(7):e0132826. PubMed ID: 26177311
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.
Pavkov ME; Weil EJ; Fufaa GD; Nelson RG; Lemley KV; Knowler WC; Niewczas MA; Krolewski AS
Kidney Int; 2016 Jan; 89(1):226-34. PubMed ID: 26398493
[TBL] [Abstract][Full Text] [Related]
6. Circulating TNF receptor levels are associated with estimated glomerular filtration rate even in healthy individuals with normal kidney function.
Gohda T; Murakoshi M; Shibata T; Suzuki Y; Takemura H; Tsuchiya K; Okada T; Wakita M; Horiuchi Y; Tabe Y; Kamei N
Sci Rep; 2024 Mar; 14(1):7245. PubMed ID: 38538662
[TBL] [Abstract][Full Text] [Related]
7. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.
Murakoshi M; Gohda T; Sonoda Y; Suzuki H; Tomino Y; Horikoshi S; Suzuki Y
Clin Exp Nephrol; 2017 Dec; 21(6):1068-1074. PubMed ID: 28389814
[TBL] [Abstract][Full Text] [Related]
8. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease.
Gohda T; Kamei N; Koshida T; Kubota M; Tanaka K; Yamashita Y; Adachi E; Ichikawa S; Murakoshi M; Ueda S; Suzuki Y
J Diabetes Investig; 2020 Mar; 11(2):435-440. PubMed ID: 31483944
[TBL] [Abstract][Full Text] [Related]
9. Assessment of serum concentration and urinary excretion of tumor necrosis factor receptor 1 and 2 and their potential as markers of immunoglobulin A nephropathy activity.
Miedziaszczyk M; Oko A; Wolc A; Woźniak A; Idasiak-Piechocka I
Adv Clin Exp Med; 2024 Jun; 33(6):583-591. PubMed ID: 37962255
[TBL] [Abstract][Full Text] [Related]
10. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
[TBL] [Abstract][Full Text] [Related]
11. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
Pavkov ME; Nelson RG; Knowler WC; Cheng Y; Krolewski AS; Niewczas MA
Kidney Int; 2015 Apr; 87(4):812-9. PubMed ID: 25272234
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis.
Idasiak-Piechocka I; Oko A; Pawliczak E; Kaczmarek E; Czekalski S
Nephrol Dial Transplant; 2010 Dec; 25(12):3948-56. PubMed ID: 20525973
[TBL] [Abstract][Full Text] [Related]
13. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.
Gohda T; Niewczas MA; Ficociello LH; Walker WH; Skupien J; Rosetti F; Cullere X; Johnson AC; Crabtree G; Smiles AM; Mayadas TN; Warram JH; Krolewski AS
J Am Soc Nephrol; 2012 Mar; 23(3):516-24. PubMed ID: 22266664
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.
Niewczas MA; Ficociello LH; Johnson AC; Walker W; Rosolowsky ET; Roshan B; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2009 Jan; 4(1):62-70. PubMed ID: 19073786
[TBL] [Abstract][Full Text] [Related]
15. TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in Type II Diabetes Mellitus.
Lampropoulou IT; Stangou Μ; Sarafidis P; Gouliovaki A; Giamalis P; Tsouchnikas I; Didangelos T; Papagianni Α
Clin Immunol; 2020 Jun; 215():108423. PubMed ID: 32304735
[TBL] [Abstract][Full Text] [Related]
16. Association between circulating tumor necrosis factor receptors and oral bacterium in patients receiving hemodialysis: a cross-sectional study.
Mikami R; Mizutani K; Gohda T; Gotoh H; Matsuyama Y; Aoyama N; Matsuura T; Kido D; Takeda K; Izumi Y; Fujiwara T; Iwata T
Clin Exp Nephrol; 2021 Jan; 25(1):58-65. PubMed ID: 32816134
[TBL] [Abstract][Full Text] [Related]
17. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
Niewczas MA; Gohda T; Skupien J; Smiles AM; Walker WH; Rosetti F; Cullere X; Eckfeldt JH; Doria A; Mayadas TN; Warram JH; Krolewski AS
J Am Soc Nephrol; 2012 Mar; 23(3):507-15. PubMed ID: 22266663
[TBL] [Abstract][Full Text] [Related]
18. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
[TBL] [Abstract][Full Text] [Related]
19. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
[TBL] [Abstract][Full Text] [Related]
20. Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.
Gohda T; Maruyama S; Kamei N; Yamaguchi S; Shibata T; Murakoshi M; Horikoshi S; Tomino Y; Ohsawa I; Gotoh H; Nojiri S; Suzuki Y
Sci Rep; 2017 Mar; 7():43520. PubMed ID: 28256549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
